...
首页> 外文期刊>The Annals of Thoracic Surgery: Official Journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association >Mitral Valve Repair for Congenital Mitral Valve Disease: Impact of the Use of a Biodegradable Annuloplasty Ring
【24h】

Mitral Valve Repair for Congenital Mitral Valve Disease: Impact of the Use of a Biodegradable Annuloplasty Ring

机译:先天性二尖瓣疾病的二尖瓣修复:使用可生物降解瓣环成形术环的影响

获取原文
           

摘要

Operative TechniqueFollow-UpStatistical AnalysisResultsGeneral OutcomesEarly OutcomeLate OutcomesReoperation and Valve FailureAssessment of Annular GrowthThis study compares the midterm results of mitral valve repair using the biodegradable ring versus repair with non-ring annuloplasty techniques for congenital mitral valve disease in young children where it was not possible to use standard commercial rings.MethodsBetween February 2006 and November 2011, 68 patients underwent mitral valve repair for congenital mitral valve disease. Thirty-nine (57%) patients underwent concomitant annuloplasty using the biodegradable ring (group A) and 29 (43%) patients using non-ring annuloplasty techniques (group B). The median age of repair was 2 years (range 1 month to 14 years).ResultsThere were no hospital deaths or major postoperative morbidity. At a median follow-up of 3.8 years (range, 2 months to 5.1 years), overall survival at 5 years was 97% ± 3% for group A and 88% ± 8% for group B (p?= 0.29). Freedom from valve failure was 90% ± 7% in group A and 74% ± 9% in group B (p?= 0.026). The freedom from reoperation was 100% in group A and 84% ± 9% in group B (p?= 0.04). The mean transmitral gradients were 4.3 ± 1.8 mm Hg in group A and 4.2 ±1.7 mm Hg in group B (p?= 0.77).ConclusionsMitral valve repair using the biodegradable ring for congenital mitral valve disease was superior compared with non-ring annuloplasty repair. Excellent survival benefit, freedom from reoperation, and valve failure without significant elevation of transmitral gradients, suggests its important role in young children with smaller annular sizes where standard commercial rings are not available or recommended.CTSNet classification:35Congenital mitral valve disease encompasses a complex variety of lesions, with various surgical strategies often required to obtain excellent corrective results. Various annuloplasty techniques to stabilize the repair have been described in the literature. Traditionally in the pediatric age group, due to the lack of commercially available annuloplasty rings in smaller patients, one has to resort to the various non-ring annuloplasty techniques. Furthermore, the reason to avoid traditional rings in the pediatric age group were due to the 2 drawbacks related to the ring exposed to foreign material that poses a risk of fibrous tissue overgrowth, which may have an impact on valve function and restricted potential for native annular growth. The concept of a biodegradable annuloplasty ring was described by Chachques and colleagues [
机译:手术技术随访统计分析结果一般结局早期结果再手术再造和瓣膜衰竭评估环形生长这项研究比较了使用可生物降解环的二尖瓣修复术与无环瓣环成形术修复无法行之先天性二尖瓣疾病的中期结果方法2006年2月至2011年11月,有68例患者因先天性二尖瓣疾病进行了二尖瓣修复。 39例(57%)患者使用可生物降解的环进行了同期瓣环成形术(A组),29例(43%)使用了非环的环形成形术(B组)进行了瓣环成形术。修复的中位年龄为2岁(范围为1个月至14岁)。结果无医院死亡或重大术后并发症。中位随访时间为3.8年(范围为2个月至5.1年),A组5年总生存率为97%±3%,B组为88%±8%(p = 0.29)。 A组无瓣膜衰竭的发生率为90%±7%,B组为74%±9%(p = 0.026)。再次手术的自由度在A组为100%,在B组为84%±9%(p = 0.04)。 A组的平均透射梯度为4.3±1.8 mm Hg,B组的平均透射梯度为4.2±1.7 mm Hg(p?= 0.77)。结论使用可生物降解环治疗先天性二尖瓣疾病的二尖瓣修复优于无环瓣环成形术修复。 CTSNet分类:35先天性二尖瓣疾病涵盖多种复杂的疾病,其出色的生存获益,无再次手术的机会以及瓣膜功能衰竭而无明显升高的透射梯度,这表明它在较小环形体的幼儿中起重要作用。对于病变,通常需要采取各种手术策略才能获得出色的矫正效果。在文献中已经描述了各种用于稳定修复的瓣膜成形术技术。传统上,在小儿年龄组中,由于在较小的患者中缺少可商购的瓣环成形术环,因此人们不得不诉诸各种非环瓣环成形术技术。此外,在小儿年龄组中避免使用传统环的原因是由于与暴露于异物的环有关的两个缺点,这存在纤维组织过度生长的风险,这可能会影响瓣膜功能并限制天然环的发展。增长。 Chachques及其同事描述了可生物降解瓣环成形术的概念[

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号